Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
13%
OVERLAP
BY WEIGHT
14
# OF OVERLAPPING
HOLDINGS
PSCH
81
HOLDINGS
19%
ALSO IN XPH
XPH
60
HOLDINGS
24%
ALSO IN PSCH
SECTOR DRIFT (PSCH minus XPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PSCH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
LIGAND PHARMACEUTICALS-CL B | 2.7% | 1.8% | 1.8% |
|
CORCEPT THERAPEUTICS INC | 3.7% | 1.7% | 1.7% |
|
ORGANON & CO. | 1.7% | 1.5% | 1.5% |
|
AMNEAL PHARMACEUTICALS, INC. CLASS A | 1.4% | 1.8% | 1.4% |
|
SUPERNUS PHARMACEUTICALS INC | 1.3% | 1.6% | 1.3% |
PSCH Overweight Relative to XPH
|
MOLINA HEALTHCARE INC | 5.0% |
|
BRIGHTSPRING HEALTH SERVICES, INC. | 4.8% |
|
KRYSTAL BIOTECH, INC. | 4.4% |
|
GLAUKOS CORP | 3.7% |
 |
ALKERMES PLC | 3.7% |
|
TG THERAPEUTICS INC | 3.6% |
|
PROTAGONIST THERAPEUTICS, INC. | 3.3% |
|
PTC THERAPEUTICS INC | 3.1% |
|
TELEFLEX INC | 2.8% |
|
VERACYTE INC | 2.1% |
PSCH Underweight Relative to XPH
|
CRINETICS PHARMACEUTICALS INC | -3.7% |
|
MBX BIOSCIENCES INC | -3.1% |
|
DEFINIUM THERAPEUTICS INC | -2.9% |
|
ENLIVEN THERAPEUTICS, INC. | -2.2% |
|
ALUMIS INC | -2.1% |
|
TREVI THERAPEUTICS, INC. | -2.1% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.0% |
|
HARROW INC | -2.0% |
|
NUVATION BIO INC CLASS A | -1.9% |
|
LIQUIDIA TECHNOLOGIES, INC. | -1.8% |